HYPAQUE SODIUM 20%
LOE ApproachingNDAURETERALSOLUTIONPriority Review
Approved
Nov 1954
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 3h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HYPAQUE SODIUM 20% is a contrast solution administered via ureteral route for diagnostic imaging procedures. It is a radiographic contrast agent used to visualize the urinary tract and related structures during urological imaging studies. The drug works by absorbing X-rays, creating contrast in radiographic images to enhance visualization of anatomical structures.
LOE Approaching
As an aging diagnostic agent approaching loss of exclusivity with moderate competitive pressure (30%), the brand team is likely focused on defending market share in specialized urology imaging centers.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on HYPAQUE SODIUM 20% offers limited career growth opportunity given the product's mature lifecycle stage and approaching loss of exclusivity. This role is best suited for professionals seeking stability in a niche diagnostic imaging segment or those transitioning into supply chain and operational excellence functions.
Product ManagerField Sales Representative
Worked on HYPAQUE SODIUM 20% at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.